Delivery Order SPE2DR25D2014-SPE2DR26FZ65Y
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count units) with a ceiling value of $16,639.53. This firm fixed-price delivery order was issued on November 7, 2025, with an ultimate completion date of November 10, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count packaging) valued at $6,334.82 under a firm fixed-price contract. The award was issued on August 13, 2025, with an ultimate completion date of August 14, 2025, and represents a non-competitive set-aside delivery against the company's larger indefinite delivery contract. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the delivery from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count units) with a ceiling value of $17,319.74. This firm fixed-price delivery order, awarded on July 24, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award carries no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,746.14 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count packaging) with a completion date of November 10, 2025. This non-competitive, firm fixed-price delivery order was issued on November 7, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is well-positioned to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Veozah 45 mg tablets (30-count units) under a firm fixed-price contract valued at $13,060.20. This delivery order, which is not set-aside for any socioeconomic category, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 billion through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $2,432.43 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count packaging) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $16,183.30 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count units). The award was made on September 8, 2025, with an ultimate completion date of September 9, 2025, under firm fixed price terms with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,470.52 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-unit supply), with an ultimate completion date of July 25, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Veozah 45 mg tablets in a 30-count package. This is a firm fixed-price delivery order with a ceiling value of $1,064.69, with an ultimate completion date of October 29, 2025. The contract was not set-aside and was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance, leveraging its position as a major...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Veozah 45 mg tablets (30-count units) with a ceiling value of $11,894.89. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by September 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ65YDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $16,687.51 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count units) on November 7, 2025, with an ultimate completion date of November 10, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical supply support to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. The company's SPE2DX prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support contract, enabling delivery of a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for Veozah, a recently approved pharmaceutical product, demonstrates the vendor's ongoing role as a key supplier within the federal medical procurement system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.7k | 11/7/25 |